Here are three things to know:
1. North America supplies the majority of spine biologics, with nearly 63 percent of the product market share. Europe is the second largest supplier with 28 percent market share.
2. North America has a consumption market share of nearly 61 percent, and Europe has a 21 percent consumption market share.
3. Medtronic, DePuy Synthes, Stryker, Nuvasive and Zimmer Biomet are leading market players.
More articles on biologics:
Vail-Summit Orthopaedics uses injectable treatments, biologics to expand care: 3 notes
Osiris Therapeutics appoints new CEO: 3 notes
SpinalCyte earns FDA clearance for fibroblast cell therapy: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
